EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

The Lancet Oncology

ISSN 1470-2045 · Elsevier BV

Latest articles

  1. Neoadjuvant nivolumab plus ipilimumab in surgically resectable hepatocellular carcinoma (PRIME-HCC): a prospective, phase 1b, single-arm trial and translational analyses

    Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Madhava Pai, Alexandra Emilia Schlaak, Duncan Spalding, Ira Godbole, Robert D Goldin, Nicole Acuti, Caroline Ward, Georgios Nteliopoulos, Vincent Yip, Sarah Slater, Poyyamozhi Rajagopal, Mikael Sodergren, Paul Tait, Nagy Habib, Robert Thomas, Eslam Maher, Francesco A Mauri, Alessio Cortellini, Julian R Marchesi, Bertram Bengsch, Rohini Sharma, David James Pinato

    Published: 2026-11DOI: 10.1016/s1470-2045(26)00331-1

  2. Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial

    Jiajia Li, Kan Yonemori, Kaoru Niimi, Satoshi Nakagawa, Kosuke Yoshihara, Shogo Shigeta, Jianqing Zhu, Hui Qiu, Jie Tang, Hidemichi Watari, Tatsuyuki Chiyoda, Shoji Nagao, Zhiqing Liang, Yuanguang Meng, Huimei Zhou, Ruifang An, Aikou Okamoto, Shin Nishio, Kazuhiro Takehara, Junzo Hamanishi, Shuzhong Yao, Fengxia Xue, Ge Lou, Hongming Pan, Wenjun Cheng, Rutie Yin, Wei Duan, Muneaki Shimada, Yixiang Zhang, Yibin Wang, Fugen Li, Juan Chen, Chenxian Dai, Chao Lv, Jihong Liu, Xiaohua Wu

    Published: 2026-11DOI: 10.1016/s1470-2045(26)00337-2

  3. Survival in patients with renal cell carcinoma and brain metastases: an update of the Renal Graded Prognostic Assessment

    Paul W Sperduto, Fasila Johri, Hany Soliman, Evan D Buckley, Kathryn E Marqueen, Enoch Chang, Jing Li, Amandeep Mahal, Rifaquat Rahman, Molly Blau, Jonathan Yang, Luke DelBalzo, Luke R G Pike, Kelsey M Frechette, William G Breen, Nuzha Noorah, G Laura Masucci, Hebah Abudawaba, Uwajachukwumma A Uzomah, John M Buatti, Eugene J Vaios, John P Kirkpatrick, Erik P Sulman, Josiah Nieto, Michelle M Kim, Mia Salans, Steve Braunstein, Sanjay Aneja, Veronica Chiang, Michael K Melton, Drexell H Boggs, Tyler Walburn, Helen A Shih, Julie Xiao, Tugce Kutuk, Rupesh Kotecha, Salah Dajani, Sean Sachdev, Geoffrey Sedor, Tony J C Wang

    Published: 2026-11DOI: 10.1016/s1470-2045(26)00385-2

  4. Cancer in the Commonwealth: a Lancet Oncology Commission

    Rifat Atun, Bhawna Sirohi, David Jaffray, Ajay Aggarwal, Ros S Ahmad Bustamam, Claudia Allemani, Lawrencia Bawuah Dsane, Gabriela Borin, Karen Canfell, M Asif Chaudry, Anna J Dare, Anbang Du, Beverley M Essue, John T Figi, Aruni Ghose, Meredith Giuliani, Jason Gurney, Michael G Head, Andre Ilbawi, Jonathan C Irish, Christopher G C A Jackson, Kristina Jenei, Sonali E Johnson, Felicia Marie Knaul, Mark Lodge, Miriam Mutebi, Christian Ntizimira, Dennis A Ostwald, C S Pramesh, Che L Reddy, Lorna A Renner, Danielle Rodin, Maike Schmitt, Zainab Shinkafi-Bagudu, Isabelle Soerjomataram, Dingle Spence, Susannah Stanway, Dorit T Stein, Sugeeta Sukumar, Zuzanna Tittenbrun

    Published: 2026-11DOI: 10.1016/s1470-2045(26)00396-7

  5. Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial

    Marloes J Hassing, Nicole E Billingy, Corina J G van den Hurk, Michel M van den Heuvel, Cornelia A Verberkt, Annemarie Becker-Commissaris, Iris Walraven, Hans J M Smit, Jeske A Staal van den Brekel, Frederieke Koppe, Judith Herder, Alle Welling, Olga C J Schuurbiers, Suzy M Samii, Wai Yee Lam-Wong, Wouter K de Jong, Katrien E A de Jaeger, Jos A Stigt, Nico C van Walree, Harm Jan Bogaard, Vashti N M F Tromp, Jacqueline G Hugtenburg, Bregje D Onwuteaka-Philipsen, José Belderbos, Lonneke van de Poll-Franse, Annemarie Becker-Commissaris, Iris Walraven

    Published: 2026-10DOI: 10.1016/s1470-2045(26)00305-0

Volumes

2026 · 3682025 · 5022024 · 5012023 · 4282022 · 5502021 · 5202020 · 5272019 · 5942018 · 6362017 · 6622016 · 6602015 · 6622014 · 6212013 · 5782012 · 5822011 · 3282010 · 3302009 · 3052008 · 3332007 · 4112006 · 4422005 · 4152004 · 3212003 · 3242002 · 3462001 · 3722000 · 150

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.